Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cooper companies - COO

COO

Close Chg Chg %
99.08 0.83 0.84%

Closed Market

99.91

+0.83 (0.84%)

Volume: 992.42K

Last Updated:

Nov 21, 2024, 4:00 PM EDT

Trade Now

Company Overview: cooper companies - COO

COO Key Data

Open

$99.08

 Day Range

98.13 - 100.04

52 Week Range

82.22 - 112.38

 Market Cap

$19.73B

Shares Outstanding

199.16M

 Public Float

198.16M

Beta

0.99

 Rev. Per Employee

N/A

P/E Ratio

55.20

 EPS

$1.81

Yield

0.00%

 Dividend

$0.03

EX-DIVIDEND DATE

Jul 26, 2023

 SHORT INTEREST

N/A

AVERAGE VOLUME

1.29M

  

COO Performance

1 Week
 
 0.28%
 
1 Month
 
 -7.34%
 
3 Months
 
 5.59%
 
1 Year
 
 17.77%
 
5 Years
 
 29.83%
 

COO Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

About cooper companies - COO

The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.

COO At a Glance

The Cooper Cos., Inc.
6101 Bollinger Canyon Road
San Ramon, California 94583
Phone 1-925-460-3600 Revenue 3.59B
Industry Medical Specialties Net Income 294.20M
Sector Health Technology 2023 Sales Growth 8.608%
Fiscal Year-end 10 / 2024 Employees 15,000
View SEC Filings

COO Valuation

P/E Current 55.201
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 52.771
Price to Sales Ratio 4.321
Price to Book Ratio 2.044
Price to Cash Flow Ratio 25.556
Enterprise Value to EBITDA 20.052
Enterprise Value to Sales 5.073
Total Debt to Enterprise Value 0.155

COO Efficiency

Revenue/Employee 239,546.667
Income Per Employee 19,613.333
Receivables Turnover 5.893
Total Asset Turnover 0.31

COO Liquidity

Current Ratio 1.759
Quick Ratio 1.00
Cash Ratio 0.125

COO Profitability

Gross Margin 60.439
Operating Margin 13.951
Pretax Margin 11.491
Net Margin 8.188
Return on Assets 2.542
Return on Equity 3.996
Return on Total Capital 2.836
Return on Invested Capital 2.939

COO Capital Structure

Total Debt to Total Equity 37.387
Total Debt to Total Capital 27.213
Total Debt to Total Assets 24.213
Long-Term Debt to Equity 36.28
Long-Term Debt to Total Capital 26.407
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cooper Companies - COO

Collapse All in section
All values USD millions. 2020 2021 2022 2023 5-year trend
Sales/Revenue
2.43B 2.92B 3.31B 3.59B
Sales Growth
-8.39% +20.22% +13.20% +8.61%
Cost of Goods Sold (COGS) incl D&A
1.03B 1.11B 1.32B 1.42B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
319.60M 341.10M 378.30M 407.70M
Depreciation
182.40M 195.00M 198.80M 221.50M
Amortization of Intangibles
137.20M 146.10M 179.50M 186.20M
COGS Growth
-0.16% +8.38% +18.76% +7.56%
Gross Income
1.40B 1.81B 1.99B 2.17B
Gross Income Growth
-13.59% +28.89% +9.79% +9.31%
Gross Profit Margin
+57.76% +61.92% +60.05% +60.44%
2020 2021 2022 2023 5-year trend
SG&A Expense
1.07B 1.28B 1.44B 1.67B
Research & Development
93.30M 92.70M 110.30M 137.40M
Other SG&A
972.70M 1.19B 1.33B 1.53B
SGA Growth
+0.93% +20.51% +11.76% +16.35%
Other Operating Expense
- - - -
-
Unusual Expense
26.30M 7.70M (4.20M) (31.80M)
EBIT after Unusual Expense
311.80M 517.40M 555.30M 533.10M
Non Operating Income/Expense
(8.50M) 5.20M (25.00M) (58.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
36.80M 31.10M 55.00M 62.20M
Interest Expense Growth
-45.88% -15.49% +76.85% +13.09%
Gross Interest Expense
42.10M 38.90M 55.00M 62.20M
Interest Capitalized
- - 5.30M 7.80M
-
Pretax Income
266.50M 491.50M 475.30M 412.90M
Pretax Income Growth
-44.18% +84.43% -3.30% -13.13%
Pretax Margin
+10.96% +16.82% +14.37% +11.49%
Income Tax
28.10M (2.45B) 89.50M 118.70M
Income Tax - Current - Domestic
2.50M 22.30M 14.00M 41.00M
Income Tax - Current - Foreign
26.50M 26.70M 21.70M 33.00M
Income Tax - Deferred - Domestic
3.20M (9.30M) 8.20M (44.20M)
Income Tax - Deferred - Foreign
(4.10M) (2.49B) 45.60M 88.90M
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
238.40M 2.94B 385.80M 294.20M
Minority Interest Expense
- - - -
-
Net Income
238.40M 2.94B 385.80M 294.20M
Net Income Growth
-48.92% +1,135.19% -86.90% -23.74%
Net Margin Growth
+9.81% +100.76% +11.66% +8.19%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
238.40M 2.94B 385.80M 294.20M
Preferred Dividends
- - - -
-
Net Income Available to Common
238.40M 2.94B 385.80M 294.20M
EPS (Basic)
1.2139 14.9629 1.9564 1.4859
EPS (Basic) Growth
-48.60% +1,132.63% -86.92% -24.05%
Basic Shares Outstanding
196.40M 196.80M 197.20M 198.00M
EPS (Diluted)
1.2016 14.7826 1.9406 1.4769
EPS (Diluted) Growth
-48.51% +1,130.24% -86.87% -23.89%
Diluted Shares Outstanding
198.40M 199.20M 198.80M 199.20M
EBITDA
657.70M 866.20M 929.40M 909.00M
EBITDA Growth
-22.59% +31.70% +7.30% -2.19%
EBITDA Margin
+27.06% +29.64% +28.09% +25.30%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 115.929
Number of Ratings 21 Current Quarters Estimate 0.95
FY Report Date 01 / 2025 Current Year's Estimate 4.083
Last Quarter’s Earnings 1.00 Median PE on CY Estimate N/A
Year Ago Earnings 3.657 Next Fiscal Year Estimate 4.56
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 11 11 17 13
Mean Estimate 0.95 0.96 4.08 4.56
High Estimates 0.99 0.99 4.18 4.86
Low Estimate 0.90 0.94 4.01 4.41
Coefficient of Variance 2.64 1.57 0.98 2.62

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 11 10 11
OVERWEIGHT 1 1 2
HOLD 8 8 6
UNDERWEIGHT 1 1 1
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Cooper Companies - COO

Date Name Shares Transaction Value
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,081 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.89 per share 512,622.09
Mar 21, 2024 Agostino Ricupati SVP & CAO 26,493 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $63.69 per share 1,687,339.17
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,081 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.89 per share 512,622.09
Mar 21, 2024 Agostino Ricupati SVP & CAO 8,325 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $57.42 per share 478,021.50
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,081 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.89 per share 512,622.09
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,569 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $32.9 per share 183,220.10
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,081 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.89 per share 512,622.09
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,133 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $40.57 per share 208,245.81
Mar 21, 2024 Agostino Ricupati SVP & CAO 5,081 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $100.89 per share 512,622.09
Mar 21, 2024 Agostino Ricupati SVP & CAO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2024 Agostino Ricupati SVP & CAO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2024 Agostino Ricupati SVP & CAO 7,384 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2024 Agostino Ricupati SVP & CAO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 21, 2024 Agostino Ricupati SVP & CAO 34,609 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $76.14 per share 2,635,129.26
Mar 21, 2024 Agostino Ricupati SVP & CAO N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 15, 2024 Robert S. Weiss Director 265,360 Bona fide gift 0.00
Mar 12, 2024 Robert S. Weiss Director 282,772 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $102.18 per share 28,893,642.96
Mar 12, 2024 Robert S. Weiss Director 88,075 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2024 Robert S. Weiss Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Mar 12, 2024 Robert S. Weiss Director 370,847 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $57.42 per share 21,294,034.74

Cooper Companies in the News